REVOBIOM leads the upcoming Microbial revolution by mimicking natural Darwinian evolution thanks to its Microbial Evolution Machine, a High-throughput millifluidic device allowing the breeding of micro-organism ecosystems. Revobiom's device directs evolution in order to enhance single strains or compose and stabilize complex ecosystems. Microbials are present in a number of industries: Food Ferments, Biofuels, Human and Animal Nutrition, Soil Fertilization, Cosmetics, and Pharmaceuticals.
| Website | https://revobiom.com |
| Employees | 5 (4 on RocketReach) |
| Founded | 2022 |
| Address | 10, Rue Vauquelin, Paris, Île-de-France 75005, FR |
| Industry | Biotechnology |
| Keywords | Directed Evolution, High Throughput Screening, Biotechnology, Microbial Consortia, Microbial Communities, Microbiome Research, Bioprocess Optimization, Biomanufacturing, Synthetic Biology, Drug Discovery, Metabolic Engineering, Precision Fermentation, Enzyme Engineering, Biocatalysis, Biosensors |
| Competitors | Novartis, AstraZeneca, Genentech, Amgen, Regeneron, Vertex Pharmaceuticals, Moderna Therapeutics, Intellia Therapeutics, Inc., CureVac, ERYTECH Pharma +44 more (view full list) |
Looking for a particular REVOBIOM employee's phone or email?
Thomas Bibette is the CEO and Co-Founder @ REVOBIOM of REVOBIOM.
4 people are employed at REVOBIOM.
REVOBIOM is based in Paris, Île-de-France.